Abstract
Objective
The aim of this study was to evaluate the feasibility and safety of type B radical hysterectomy (RH) in the management of patients affected by locally advanced cervical cancer with favorable prognostic factors (tumor diameter <40 mm, negative nodes, or lymphovascular space involvement) and clinical response to neoadjuvant chemotherapy (NACT).
Methods
The data of women undergoing platinum-based NACT followed by RH plus bilateral systematic pelvic lymphadenectomy were collected. Patients undergoing type B RH (Group A) were compared with those undergoing type C RH (Group B); a propensity-matched comparison (1:1) was carried out to minimize selection biases. Postoperative complications were reported and 5-year survival outcomes were assessed using the Kaplan–Meier model.
Results
Thirty-six node-negative patients undergoing type B RH (Group A) were compared with 36 propensity-matched patients undergoing type C RH (Group B). The bladder dysfunction rate was significantly lower in Group A compared with Group B (13.9 vs. 69.4 %; p < 0.0001), and no statistically significant difference in 5-year overall survival (OS) and disease-free survival (DFS) between groups was reported (OS 93.0 vs. 96.7 %, p = 0.42; DFS 88.6 and 85.5 %, p = 0.77).
Conclusions
Type B RH after NACT in well-selected patients is a safe procedure that upholds the results of type C, reducing operative time and late postoperative morbidity, without detrimental effect on survival. Further prospective trials are warranted to confirm our results on a large scale.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–30.
Benedetti Panici P, Greggi S, Scambia G, et al. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer. 1998;34(3):341–6.
Benedetti Panici P, Bellati F, Pastore M, et al. An update in neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol. 2007;107(1):20–2.
Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA) Collaboration. Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev. 2004;(2):CD001774.
Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39(17):2470–86.
Benedetti Panici P, Scambia G, Greggi S, Di Roberto PF, Baiocchi G, Mancuso S. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol. 1988;71:344–8.
Piver S, Rutledge F, Smith JP. Five classes of extended hysterectomy. Am J Obstet Gynecol. 1974;44:265–72.
Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303.
Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.
Benedetti Panici P, Angioli R, Palaia I, Muzii L, Zullo MA, Manci N, et al. Tailoring the parametrectomy in stages IA1-IB1 cervical carcinoma: is it feasible and safe? Gynecol Oncol. 2005;96:792–8.
Bogani G, Cromi A, Uccella S, Serati M, Casarin J, Pinelli C, et al. Laparoscopic versus open abdominal management of cervical cancer: long-term results from a propensity-matched analysis. J Minim Invasive Gynecol. 2014;21(5):857–62.
Benedetti Panici P, Manci N, Di Donato et al. Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence. Int J Gynecol Cancer. 2009;19(9):1625–31.
Benedetti Panici P, Zullo MA, Plotti F, Manci N, Muzii L, Angioli R. Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy. Cancer. 2004;100: 2110–7.
Plotti F, Sansone M, Di Donato V, Antonelli A, Altavilla T, Angioli R, et al. Quality of life and sexual function after type C2/type III radical hysterectomy for locally advanced cervical cancer: a prospective study. J Sex Med. 2011;8:894–904.
Benedetti Panici P, Maneschi F, D’Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer. 2000;88(10):2267–74.
Martinelli F, Bogani G, Ditto A, et al. How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy? Eur J Surg Oncol. 2015;41(8):1089–96.
Landoni F, Sartori E, Maggino T, et al. Is there a role for postoperative treatment in patients with stage Ib2–IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study. Gynecol Oncol. 2014;132:611–7.
Papadia A, Bellati F, Bogani G, Ditto A, Martinelli F, Lorusso D, et al. When does neoadjuvant chemotherapy really avoid radiotherapy? Clinical predictors of adjuvant radiotherapy in cervical cancer. Ann Surg Oncol. 2015.
Cibula D, Abu-Rustum NR, Benedetti-Panici P, Köhler C, Raspagliesi F, Querleu D, et al. New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. Gynecol Oncol. 2011;122(2):264–8.
Barnes W, Waggoner S, Delgado G, Maher K, Potkul R, Barter J, et al. Manometric characterization of rectal dysfunction following radical hysterectomy. Gynecol Oncol. 1991;42:116–9.
Zullo MA, Manci N, Angioli R, Muzii L, Benedetti Panici P. Vescical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48(3):287–93.
Plotti F, Nelaj E, Sansone M, et al. Sexual function after modified radical hysterectomy (Piver II/type B) vs. classic radical hysterectomy (Piver III/type C2) for early stage cervical cancer. A prospective study. J Sex Med 2012;9(3):909–17.
Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB. Vaginal cancer. Crit Rev Oncol Hematol. 2012;81(3):286–95
Author information
Authors and Affiliations
Corresponding author
Additional information
Pierluigi Benedetti Panici and Violante Di Donato have contributed equally to this article.
Rights and permissions
About this article
Cite this article
Panici, P.B., Di Donato, V., Palaia, I. et al. Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis. Ann Surg Oncol 23, 2176–2182 (2016). https://doi.org/10.1245/s10434-015-4996-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-015-4996-z